News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,267 Results
Type
Article (42131)
Company Profile (318)
Press Release (692799)
Multimedia
Podcasts (121)
Webinars (23)
Section
Business (207691)
Career Advice (2096)
Deals (36014)
Drug Delivery (126)
Drug Development (82795)
Employer Resources (182)
FDA (16544)
Job Trends (15280)
News (351568)
Policy (33086)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2600)
Accelerated approval (39)
Adcomms (25)
Allergies (157)
Alliances (50381)
ALS (191)
Alzheimer's disease (1752)
Antibody-drug conjugate (ADC) (368)
Approvals (16840)
Artificial intelligence (595)
Autoimmune disease (216)
Automation (48)
Bankruptcy (364)
Best Places to Work (11757)
BIOSECURE Act (22)
Biosimilars (203)
Biotechnology (212)
Bladder cancer (176)
Brain cancer (65)
Breast cancer (683)
Cancer (5251)
Cardiovascular disease (445)
Career advice (1774)
Career pathing (44)
CAR-T (295)
CDC (57)
Celiac Disease (2)
Cell therapy (801)
Cervical cancer (40)
Clinical research (71149)
Collaboration (1892)
Company closure (4)
Compensation (1258)
Complete response letters (72)
COVID-19 (2748)
CRISPR (98)
C-suite (971)
Cystic fibrosis (147)
Data (6900)
Decentralized trials (2)
Denatured (34)
Depression (155)
Diabetes (540)
Diagnostics (6831)
Digital health (50)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (283)
Drug pricing (199)
Drug shortages (28)
Duchenne muscular dystrophy (267)
Earnings (91932)
Editorial (67)
Employer branding (23)
Employer resources (156)
Events (120721)
Executive appointments (1044)
FDA (19894)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1587)
Gene editing (211)
Generative AI (51)
Gene therapy (659)
GLP-1 (1035)
Government (4748)
Grass and pollen (7)
Guidances (392)
Healthcare (18995)
HIV (73)
Huntington's disease (51)
IgA nephropathy (87)
Immunology and inflammation (270)
Immuno-oncology (79)
Indications (153)
Infectious disease (3055)
Inflammatory bowel disease (203)
Inflation Reduction Act (15)
Influenza (126)
Intellectual property (269)
Interviews (333)
IPO (16888)
IRA (51)
Job creations (3852)
Job search strategy (1477)
JPM (65)
Kidney cancer (18)
Labor market (96)
Layoffs (571)
Leadership (41)
Legal (8004)
Liver cancer (94)
Longevity (28)
Lung cancer (701)
Lymphoma (401)
Machine learning (52)
Management (59)
Manufacturing (900)
MASH (182)
Medical device (13850)
Medtech (13925)
Mergers & acquisitions (20274)
Metabolic disorders (1408)
mRNA (178)
Multiple sclerosis (174)
NASH (17)
Neurodegenerative disease (376)
Neuropsychiatric disorders (98)
Neuroscience (3127)
Neurotech (1)
NextGen: Class of 2026 (6583)
Non-profit (4542)
Now hiring (73)
Obesity (667)
Opinion (296)
Ovarian cancer (179)
Pain (223)
Pancreatic cancer (250)
Parkinson's disease (334)
Partnered (33)
Patents (541)
Patient recruitment (572)
Peanut (60)
People (60059)
Pharmaceutical (74)
Pharmacy benefit managers (32)
Phase 1 (22208)
Phase 2 (31377)
Phase 3 (23259)
Pipeline (6683)
Policy (321)
Postmarket research (2574)
Preclinical (9421)
Press Release (64)
Prostate cancer (270)
Psychedelics (51)
Radiopharmaceuticals (308)
Rare diseases (976)
Real estate (6083)
Recruiting (72)
Regulatory (25131)
Reports (58)
Research institute (2426)
Resumes & cover letters (358)
Rett syndrome (32)
RNA editing (16)
RSV (85)
Schizophrenia (156)
Series A (267)
Series B (197)
Service/supplier (11)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (160)
Sponsored (46)
Startups (3707)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (91)
The Weekly (85)
Vaccines (1061)
Venture capital (101)
Weight loss (425)
Women's health (110)
Worklife (23)
Date
Today (133)
Last 7 days (650)
Last 30 days (3081)
Last 365 days (30495)
2026 (7122)
2025 (30584)
2024 (35725)
2023 (40660)
2022 (51786)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35386)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (760)
Alabama (93)
Alaska (7)
Arizona (326)
Arkansas (14)
Asia (40740)
Australia (6585)
California (12133)
Canada (3470)
China (1235)
Colorado (514)
Connecticut (518)
Delaware (362)
Europe (88426)
Florida (1843)
Georgia (382)
Hawaii (3)
Idaho (61)
Illinois (943)
India (76)
Indiana (554)
Iowa (22)
Japan (476)
Kansas (128)
Kentucky (44)
Louisiana (35)
Maine (73)
Maryland (1485)
Massachusetts (8744)
Michigan (343)
Minnesota (662)
Mississippi (6)
Missouri (136)
Montana (33)
Nebraska (29)
Nevada (132)
New Hampshire (82)
New Jersey (3224)
New Mexico (29)
New York (3198)
North Carolina (1601)
North Dakota (8)
Northern California (5981)
Ohio (359)
Oklahoma (22)
Oregon (42)
Pennsylvania (2444)
Puerto Rico (26)
Rhode Island (50)
South America (1136)
South Carolina (73)
South Dakota (1)
Southern California (4757)
Tennessee (195)
Texas (1899)
United States (43122)
Utah (362)
Vermont (1)
Virginia (289)
Washington D.C. (80)
Washington State (988)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
735,267 Results for "sutro biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
March 24, 2026
·
12 min read
Press Releases
Sutro Biopharma to Participate in Upcoming March 2026 Investor Conferences
February 25, 2026
·
1 min read
Press Releases
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
February 23, 2026
·
1 min read
Press Releases
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
February 10, 2026
·
5 min read
Press Releases
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
·
1 min read
Press Releases
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 18, 2025
·
3 min read
Press Releases
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
December 2, 2025
·
5 min read
Layoffs
Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout
After parting with 50% of its employees earlier this year, Sutro Biopharma will lay another third of its staff in a restructuring effort geared toward reaching key inflection points.
September 30, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 16, 2025
December 17, 2025
·
1 min read
Press Releases
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
November 5, 2025
·
1 min read
1 of 73,527
Next
